3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Motor Activity
15
Neoplasms
11
Breast Neoplasms
11
Prostatic Neoplasms
7
Obesity
5
Head and Neck Neoplasms
5
Signs and Symptoms
3
Sarcopenia
3
Polycystic Ovary Syndrome
3
Lung Neoplasms
3
Diabetes Mellitus, Type 2
3
Colorectal Neoplasms
3
Uterine Cervical Neoplasms
2
Pharyngeal Neoplasms
2
Osteoporosis, Postmenopausal
2
Osteoporosis
2
Lymphoma
2
Leukemia
2
Laryngeal Neoplasms
2
Fatigue
2
Diabetes Mellitus
2
Weight Loss
1
Uterine Neoplasms
1
Urinary Incontinence
1
Stroke
1
Squamous Cell Carcinoma of Head and Neck
1
Sedentary Behavior
1
Sarcoma, Synovial
1
Sarcoma, Ewing
1
Sarcoma
1
Interventions
Gemcitabine
7
130-nm albumin-bound paclitaxel
5
Fluorouracil
3
Albumin-Bound Paclitaxel
3
dehydroftorafur
2
Taxes
2
Oxaliplatin
2
tocilizumab
1
selicrelumab
1
niraparib
1
cobimetinib
1
atezolizumab
1
Tiragolumab
1
Resistance Training
1
Radiotherapy, Intensity-Modulated
1
Radiotherapy, Image-Guided
1
Radiotherapy, Conformal
1
Pancreatectomy
1
PEGPH20
1
Nivolumab
1
Leucovorin
1
Irinotecan
1
Ipilimumab
1
Interleukin 1 Receptor Antagonist Protein
1
Erlotinib Hydrochloride
1
Electronic Health Records
1
Cisplatin
1
Bevacizumab
1
4-fluorobenzoyl-TN-14003
1
3-aminopyridine-2-carboxaldehyde thiosemicarbazone
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Completed
×
Pancreatic Adenocarcinoma
×
Resistance Training
×
Clear all
NCT02680990
2018-02-28
REACT
Milton S. Hershey Medical Center
Phase NA
Completed
14 enrolled